Showing 1 of 1 recruiting trials for “Mucinous adenocarcinoma of ovary”
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
👨⚕️ Christina Washington, MD, OU Health Stephenson Cancer Center📍 4 sites📅 Started Feb 2023View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →